Adenocarcinoma involving esophago-gastric junction (EGJ) is usually originated from the gastric cardia and it presents unique cli8nical manifestations, requires special surgical care, and bears a much poor prognosis.
We analyse the clinical data of 109 adenocarcinoma involving EGJ operated between August, 1987 and March, 1994. Curative resection of primary tumor including esophagus and lymph node dissection was possible o 102 cases (93.5%). Among these cases,
89
cases were advanced state over the stage Ⅲ. The operative mortality was 1.8% and postoperative morbidity was 16.5%. The overall 3 year and 5 year survival rate was 48.5%, 34.1% each, and median survival was 27m5 month in the curative resected
cases.
The treatment failure was mainly distant metastsis including lymph node, except one local recurrence.
Among many factory influencing long term results of resected adenocarcinoma involving EGJ, the only effort a surgeon can make is to attain completeness of tumor removal by dissecting all involved lymph node and ensuring adequate tumor free
margins
o
both esophageal and cardiac side.
(Korean J Thorac Cardiovasc Surg 1995;28:01144-9)
|